BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35979157)

  • 1. Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population.
    Jiang HH; Xing SW; Tang X; Chen Y; Lin K; He LW; Lin MB; Tang EJ
    World J Gastroenterol; 2022 Jun; 28(24):2705-2732. PubMed ID: 35979157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of multitarget stool DNA testing in African American patients.
    Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
    Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.
    Ahlquist DA; Zou H; Domanico M; Mahoney DW; Yab TC; Taylor WR; Butz ML; Thibodeau SN; Rabeneck L; Paszat LF; Kinzler KW; Vogelstein B; Bjerregaard NC; Laurberg S; Sørensen HT; Berger BM; Lidgard GP
    Gastroenterology; 2012 Feb; 142(2):248-56; quiz e25-6. PubMed ID: 22062357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
    Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection.
    Xu H; Chen H; Hu J; Xiong Z; Li D; Wang S; Yu J
    BMC Gastroenterol; 2022 Aug; 22(1):384. PubMed ID: 35963995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions.
    Gagrat ZD; Krockenberger M; Bhattacharya A; Gagrat BZ; Leduc CM; Matter MB; Fourrier KD; Mahoney DW; Edwards V DK; Lidgard GP; Limburg PJ; Johnson SC; Domanico MJ; Kisiel JB
    Cancer Prev Res (Phila); 2024 Mar; 17(3):119-126. PubMed ID: 38224564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
    Heigh RI; Yab TC; Taylor WR; Hussain FT; Smyrk TC; Mahoney DW; Domanico MJ; Berger BM; Lidgard GP; Ahlquist DA
    PLoS One; 2014; 9(1):e85659. PubMed ID: 24465639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Dollinger MM; Behl S; Fleig WE
    Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal DNA Testing for Colorectal Cancer Screening.
    Carethers JM
    Annu Rev Med; 2020 Jan; 71():59-69. PubMed ID: 31451044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative detection of aberrantly methylated DNA in preoperative and postoperative stool from patients with colorectal cancers.
    Nishioka Y; Ueki T; Hokazono K; Nagayoshi K; Tanaka M
    Int J Biol Markers; 2015; 30(1):e81-7. PubMed ID: 24980446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.